SCHEMBL4736670

SCHEMBL4736670

O=S(=O)(NC(CO)Cc1cc2cnn(-c3ccc(F)cc3)c2cc1Cl)c1ccc(S(=O)(=O)N2CCCC2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 7/20 0.41
PGR P06401 4/20 0.41
POLB P06746 4/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
GAA P10253 1/20 0.40
MAPT P10636 2/20 0.39
CCR1 P32246 3/20 0.39
AR P10275 3/20 0.38
ALDH1A1 P00352 3/20 0.37
KDM4E B2RXH2 2/20 0.37
MEN1 O00255 2/20 0.37
HPGD P15428 2/20 0.37
KMT2A Q03164 2/20 0.37
SMO Q99835 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C19 P33261 1/20 0.37
PPARG P37231 1/20 0.37
NCOA2 Q15596 1/20 0.37
NCOA1 Q15788 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4733246 0.70 NR3C1 (0.49) NR3C1PGRARSMO
SCHEMBL14144150 0.68 NR3C1 (0.49) NR3C1PGRCCR1ARSMO
SCHEMBL4737732 0.67 SMO (0.44) NR3C1PGRARSMO
SCHEMBL14144304 0.65 NR3C1 (0.50) NR3C1PGRCCR1SMO
SCHEMBL4552036 0.64 NR3C1 (0.53) NR3C1PGRARSMO
SCHEMBL14144337 0.63 NR3C1 (0.61) NR3C1PGRARCYP3A4
SCHEMBL441369 0.63 NR3C1 (0.57) NR3C1PGR
SCHEMBL26495603 0.63 LRRK2 (0.41) NR3C1PGRCCR1ARSMO
SCHEMBL3236916 0.62 MAPT (0.80) POLBSMN1; SMN2GAAMAPTALDH1A1
SCHEMBL24153234 0.62 LRRK2 (0.43) NR3C1PGRCCR1ARKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008079073-A1 INDAZOLYL SULPHONAMIDE DERIVATIVES FOR THE TREATMENT OF GLUCOCORTICOID RECEPTOR MEDIATED DISORDERS ASTRAZENECA AB (SE) 2008-07-03 WO disclosed